Evan Lipson, MD, discusses the evolving treatment landscape for advanced melanoma.
Evan Lipson, MD
Advertisement
Evan Lipson, MD, is an associate professor of oncology at John Hopkins School of Medicine and a head and neck oncologist at John Hopkins Medicine.
Articles by Evan Lipson, MD
Evan Lipson, MD, discusses feedback he ’s received from colleagues about responses in patients with melanoma.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
4
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
5
